Vironexis Biotherapeutics: Funding, Investors & Team (Oct 2026)
Vironexis will implement the cutting-edge technique of AAV-delivered T-cell immunotherapy.
Vironexis Biotherapeutics has raised $26.0M across 1 funding round on record, the most recent a Seed of $26.0M announced in Sep 2024.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Vironexis Biotherapeutics Company Profile and Key Stats
Latest funding round on record: Sep 2024.
Vironexis Biotherapeutics Funding Rounds
Vironexis Biotherapeutics Founders and Leadership Team
Contact details for the Vironexis Biotherapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Vironexis Biotherapeutics Funding Compared to Other Biotechnology Startups
Vironexis Biotherapeutics' latest round of $26.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Vironexis Biotherapeutics in Biotechnology and California
Companies Similar to Vironexis Biotherapeutics
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Datavant is a developer of a healthcare data platform dedicated to assisting in protecting, matching, and…
Vironexis Biotherapeutics Funding FAQs
What does Vironexis Biotherapeutics do?
Vironexis will implement the cutting-edge technique of AAV-delivered T-cell immunotherapy.
How much funding has Vironexis Biotherapeutics raised?
Vironexis Biotherapeutics has raised $26.0M across 1 round on record. The most recent is a Seed of $26.0M announced in Sep 2024.
When did Vironexis Biotherapeutics last raise funding?
Vironexis Biotherapeutics' most recent funding round on record is a Seed of $26.0M, announced in Sep 2024.
Who founded Vironexis Biotherapeutics?
FundedIQ lists Brian Kaspar (Founder) at Vironexis Biotherapeutics.
Where is Vironexis Biotherapeutics headquartered?
Vironexis Biotherapeutics is based in California, Kentucky, United States.
How many employees does Vironexis Biotherapeutics have?
Vironexis Biotherapeutics is in the 11-50 employee band.
How does Vironexis Biotherapeutics' funding compare to other Biotechnology startups?
Vironexis Biotherapeutics' latest round of $26.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Vironexis Biotherapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Vironexis Biotherapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.